OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Oncogenic Pathways and Targeted Therapies in Ovarian Cancer
Carolina Lliberos, Gary Richardson, Antonella Papa
Biomolecules (2024) Vol. 14, Iss. 5, pp. 585-585
Open Access | Times Cited: 7
Carolina Lliberos, Gary Richardson, Antonella Papa
Biomolecules (2024) Vol. 14, Iss. 5, pp. 585-585
Open Access | Times Cited: 7
Showing 7 citing articles:
Precision medicine in gynecological cancer (Review)
Aikaterini Aravantinou‐Fatorou, Vasiliki Georgakopoulou, Meletios Α. Dimopoulos, et al.
Biomedical Reports (2025) Vol. 22, Iss. 3
Open Access
Aikaterini Aravantinou‐Fatorou, Vasiliki Georgakopoulou, Meletios Α. Dimopoulos, et al.
Biomedical Reports (2025) Vol. 22, Iss. 3
Open Access
High Frequency of PIK3R1 Alterations in Ovarian Cancers: Clinicopathological and Molecular Associations
Iwona K. Rzepecka, Andrzej Tysarowski, Bożena Konopka, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 269-269
Open Access
Iwona K. Rzepecka, Andrzej Tysarowski, Bożena Konopka, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 269-269
Open Access
Oncolytic Viruses in Ovarian Cancer: Where Do We Stand? A Narrative Review
Fulvio Borella, Marco Carosso, Maria Pia Chiparo, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 140-140
Open Access
Fulvio Borella, Marco Carosso, Maria Pia Chiparo, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 140-140
Open Access
Investigation of the mechanism by which FOXJ2 inhibits proliferation, metastasis and cell cycle progression of ovarian cancer cells through the PI3K/AKT signaling pathway
Liyuan Wang, Han He, Ruifang Zhai, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Liyuan Wang, Han He, Ruifang Zhai, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Folate Receptor Alpha—A Secret Weapon in Ovarian Cancer Treatment?
Karol Bukowski, Aneta Rogalska, Agnieszka Marczak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11927-11927
Open Access | Times Cited: 1
Karol Bukowski, Aneta Rogalska, Agnieszka Marczak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11927-11927
Open Access | Times Cited: 1
Reclassify High-Grade Serous Ovarian Cancer Patients Into Different Molecular Subtypes With Discrepancy Prognoses and Therapeutic Responses Based on Cancer-Associated Fibroblast-Enriched Prognostic Genes
Xiangxiang Liu, Guoqiang Ping, Dongze Ji, et al.
Biomedical Engineering and Computational Biology (2024) Vol. 15
Open Access
Xiangxiang Liu, Guoqiang Ping, Dongze Ji, et al.
Biomedical Engineering and Computational Biology (2024) Vol. 15
Open Access
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy
Sébastien Taurin, Reem Alzahrani, Sahar Aloraibi, et al.
Translational Oncology (2024) Vol. 51, pp. 102226-102226
Closed Access
Sébastien Taurin, Reem Alzahrani, Sahar Aloraibi, et al.
Translational Oncology (2024) Vol. 51, pp. 102226-102226
Closed Access
Enterolactone combined with m6A Reader IGF2BP3 inhibits Malignant Angiogenesis and Disease Progression in Ovarian Cancer
Mengzhi Xu, Yi Guo, Fengge Wang, et al.
Phytomedicine (2024) Vol. 136, pp. 156343-156343
Closed Access
Mengzhi Xu, Yi Guo, Fengge Wang, et al.
Phytomedicine (2024) Vol. 136, pp. 156343-156343
Closed Access
